Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
Australia
GenesisCare North Shore (Oncology), Saint Leonards, New South Wales Macquarie University Hospital, Sydney, New South Wales John Flynn Private Hospital, Tugun, Queensland GenesisCare St Andrews, Adelaide, South Australia Peninsula and South Eastern Haematology & Oncology Group, Frankston, Victoria China
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing Municipality